Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04860518
Status:
TERMINATED
Last Update Posted:
2023-07-21
First Post:
2021-04-22
Brief Title:
Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19
Sponsor:
Faron Pharmaceuticals Ltd
Organization:
Faron Pharmaceuticals Ltd
Organization Data
Organization:
Faron Pharmaceuticals Ltd
Class:
INDUSTRY
Study ID:
FP1CLI017
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Faron Pharmaceuticals Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None